These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
819 related items for PubMed ID: 26701853
1. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma. Wang F, Feng Y, Li P, Wang K, Feng L, Liu YF, Huang H, Guo YB, Mao QS, Xue WJ. Oncotarget; 2016 Jan 26; 7(4):4279-97. PubMed ID: 26701853 [Abstract] [Full Text] [Related]
2. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma. Hirata H, Sugimachi K, Komatsu H, Ueda M, Masuda T, Uchi R, Sakimura S, Nambara S, Saito T, Shinden Y, Iguchi T, Eguchi H, Ito S, Terashima K, Sakamoto K, Hirakawa M, Honda H, Mimori K. Cancer Res; 2016 Jun 01; 76(11):3265-76. PubMed ID: 27197151 [Abstract] [Full Text] [Related]
3. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. Lei X, Li YF, Chen GD, Ou DP, Qiu XX, Zuo CH, Yang LY. Oncotarget; 2015 Dec 01; 6(38):40622-41. PubMed ID: 26536663 [Abstract] [Full Text] [Related]
4. Hypermethylation of FOXD3 suppresses cell proliferation, invasion and metastasis in hepatocellular carcinoma. He G, Hu S, Zhang D, Wu P, Zhu X, Xin S, Lu G, Ding Y, Liang L. Exp Mol Pathol; 2015 Oct 01; 99(2):374-82. PubMed ID: 26112097 [Abstract] [Full Text] [Related]
5. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma. Zhang XF, Chao J, Pan QZ, Pan K, Weng DS, Wang QJ, Zhao JJ, He J, Liu Q, Jiang SS, Chen CL, Zhang HX, Xia JC. Oncotarget; 2015 Dec 01; 6(38):40920-33. PubMed ID: 26506518 [Abstract] [Full Text] [Related]
7. Stanniocalcin-1 Reduces Tumor Size in Human Hepatocellular Carcinoma. Yeung BH, Shek FH, Lee NP, Wong CK. PLoS One; 2015 Dec 01; 10(10):e0139977. PubMed ID: 26469082 [Abstract] [Full Text] [Related]
8. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells. Zhu M, Li M, Wang T, Linghu E, Wu B. Tumour Biol; 2016 Oct 01; 37(10):13995-14008. PubMed ID: 27492460 [Abstract] [Full Text] [Related]
9. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma. Cui M, Sun J, Hou J, Fang T, Wang X, Ge C, Zhao F, Chen T, Xie H, Cui Y, Yao M, Li J, Li H. Tumour Biol; 2016 Oct 01; 37(10):13521-13531. PubMed ID: 27465557 [Abstract] [Full Text] [Related]
10. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1. Jin H, Wang C, Jin G, Ruan H, Gu D, Wei L, Wang H, Wang N, Arunachalam E, Zhang Y, Deng X, Yang C, Xiong Y, Feng H, Yao M, Fang J, Gu J, Cong W, Qin W. Gastroenterology; 2017 Sep 01; 153(3):799-811.e33. PubMed ID: 28583823 [Abstract] [Full Text] [Related]
11. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma. Lian J, Jing Y, Dong Q, Huan L, Chen D, Bao C, Wang Q, Zhao F, Li J, Yao M, Qin L, Liang L, He X. Oncotarget; 2016 Jan 19; 7(3):2672-83. PubMed ID: 26684241 [Abstract] [Full Text] [Related]
12. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A. Yang Y, Hou N, Wang X, Wang L, Chang S, He K, Zhao Z, Zhao X, Song T, Huang C. Oncotarget; 2015 Jun 30; 6(18):16227-38. PubMed ID: 26023735 [Abstract] [Full Text] [Related]
14. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K, Dou C, Zheng X, Li C, Yang W, Yao Y, Liu Q. BMC Cancer; 2014 Dec 12; 14():938. PubMed ID: 25494879 [Abstract] [Full Text] [Related]
15. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma. Zhao R, Wang N, Huang H, Ma W, Yan Q. Liver Int; 2014 Jul 12; 34(6):e151-60. PubMed ID: 24529164 [Abstract] [Full Text] [Related]
16. Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas. Fang T, Cui M, Sun J, Ge C, Zhao F, Zhang L, Tian H, Zhang L, Chen T, Jiang G, Xie H, Cui Y, Yao M, Li H, Li J. Oncotarget; 2015 Jun 30; 6(18):16106-19. PubMed ID: 25965830 [Abstract] [Full Text] [Related]
17. microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression. Heo MJ, Kim YM, Koo JH, Yang YM, An J, Lee SK, Lee SJ, Kim KM, Park JW, Kim SG. Oncotarget; 2014 May 15; 5(9):2792-806. PubMed ID: 24798342 [Abstract] [Full Text] [Related]
18. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma. Hou X, Peng JX, Hao XY, Cai JP, Liang LJ, Zhai JM, Zhang KS, Lai JM, Yin XY. Ann Surg Oncol; 2014 Nov 15; 21(12):3891-9. PubMed ID: 24306662 [Abstract] [Full Text] [Related]
19. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis. Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A. Ann Surg Oncol; 2010 Mar 15; 17(3):923-32. PubMed ID: 19898900 [Abstract] [Full Text] [Related]